DK302782A - Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden - Google Patents

Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden Download PDF

Info

Publication number
DK302782A
DK302782A DK302782A DK302782A DK302782A DK 302782 A DK302782 A DK 302782A DK 302782 A DK302782 A DK 302782A DK 302782 A DK302782 A DK 302782A DK 302782 A DK302782 A DK 302782A
Authority
DK
Denmark
Prior art keywords
eucalyptol
bio
preparation
affecting
agents
Prior art date
Application number
DK302782A
Other languages
English (en)
Inventor
J A Zupan
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23075402&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK302782(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK302782A publication Critical patent/DK302782A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK302782A 1981-07-07 1982-07-06 Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden DK302782A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/280,967 US4440777A (en) 1981-07-07 1981-07-07 Use of eucalyptol for enhancing skin permeation of bio-affecting agents

Publications (1)

Publication Number Publication Date
DK302782A true DK302782A (da) 1983-01-08

Family

ID=23075402

Family Applications (1)

Application Number Title Priority Date Filing Date
DK302782A DK302782A (da) 1981-07-07 1982-07-06 Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden

Country Status (9)

Country Link
US (1) US4440777A (da)
EP (1) EP0069385B1 (da)
JP (1) JPS5815910A (da)
AT (1) ATE30209T1 (da)
DE (1) DE3277453D1 (da)
DK (1) DK302782A (da)
GR (1) GR77254B (da)
IE (1) IE53467B1 (da)
PT (1) PT75208B (da)

Families Citing this family (84)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3264782D1 (en) * 1981-10-16 1985-08-22 Sanol Arznei Schwarz Gmbh Medicinal formulation
US4552872A (en) * 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
US4931283A (en) * 1983-12-22 1990-06-05 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4933184A (en) * 1983-12-22 1990-06-12 American Home Products Corp. (Del) Menthol enhancement of transdermal drug delivery
US4605670A (en) * 1984-02-01 1986-08-12 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering metoclopramide
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) * 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
EP0182635B1 (en) * 1984-11-15 1989-05-31 Nitto Denko Corporation Composition for percutaneous administration
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
US4756710A (en) * 1985-04-05 1988-07-12 Merck & Co., Inc. pH-Mediated drug delivery system
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5073544A (en) * 1986-08-15 1991-12-17 Whitby, Inc. Transdermal compositions of 1-oxohydrocarbyl-substituted azacyclohexanes
CA1308352C (en) * 1986-08-15 1992-10-06 James V. Peck Compositions comprising 1-oxohydrocarbyl-substituted azacyclohexanes
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4971800A (en) * 1988-07-08 1990-11-20 The Regents Of The University Of California Method and compositions for enhancing the cutaneous penetration of pharmacologically active agents
US5051260A (en) * 1987-07-16 1991-09-24 The Regents Of The University Of California Method and composition for enhancing the cutaneous penetration of pharmacologically active agents
US5045317A (en) * 1987-07-16 1991-09-03 The Regents Of The University Of California Enhancing the cutaneous penetration of pharmacologically active agents
US4920101A (en) * 1987-09-30 1990-04-24 Nelson Research & Development Co. Compositions comprising 1-oxo- or thiohydrocarbyl substituted azacycloaklkanes
US4879275A (en) * 1987-09-30 1989-11-07 Nelson Research & Development Co. Penetration enhancers for transdermal delivery of systemic agent
US5019395A (en) * 1988-03-08 1991-05-28 Warner-Lambert Company Compositions with enhanced penetration
AU622162B2 (en) * 1988-04-22 1992-04-02 Ciba-Geigy Ag Transdermal monolith systems
US4866050A (en) * 1988-04-27 1989-09-12 Ben Amoz Daniel Ultrasonic transdermal application of steroid compositions
HU199678B (en) * 1988-07-08 1990-03-28 Egyt Gyogyszervegyeszeti Gyar Process for producing aerosols containing nitroglicerol
US5059426A (en) * 1989-03-22 1991-10-22 Cygnus Therapeutic Systems Skin permeation enhancer compositions, and methods and transdermal systems associated therewith
US4933362A (en) * 1989-06-06 1990-06-12 Jack Loomstein Sunburn treatment composition
US4975269A (en) * 1989-07-31 1990-12-04 Leonard Chavkin Shelf stable aspirin solutions
GB8921710D0 (en) * 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
EP0523150A4 (en) * 1990-04-06 1993-09-29 Pharmetrix Corporation Device and method for enhanced administration of physostigmine
US5370862A (en) * 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
EP0609330A1 (en) * 1991-10-26 1994-08-10 FLOCKHART, Ian Composition for topical application
AU2808492A (en) * 1991-10-26 1993-05-21 East Riding Laboratories Limited Medicament composition for topical application
US5230897A (en) * 1991-10-31 1993-07-27 G. D. Searle & Co. Transdermal pentamidine
US5229130A (en) * 1991-12-20 1993-07-20 Cygnus Therapeutics Systems Vegetable oil-based skin permeation enhancer compositions, and associated methods and systems
US5900250A (en) * 1992-05-13 1999-05-04 Alza Corporation Monoglyceride/lactate ester permeation enhancer for oxybutnin
US5278172A (en) * 1992-07-24 1994-01-11 Hennessey Richard K Method and composition for treating tendon or joint inflammation using a vasodilator
US5576329A (en) * 1992-07-24 1996-11-19 Hennessey; Richard K. Method for treating tendon or joint inflammation with papaverine HCL
DE69330388T2 (de) * 1992-12-31 2002-01-03 Sunkyong Ind Ltd Pharmazeutische zusammensetzungen mit verbesserter perkutaner absorption für piroxicam
JPH0753381A (ja) * 1993-07-09 1995-02-28 Ciba Geigy Ag 局所投与可能な亜鉛フタロシアニン組成物
CA2165802A1 (en) * 1993-09-29 1995-04-06 Eun Soo Lee Monoglyceride/lactate ester permeation enhancer for oxybutynin
DE4341572C1 (de) * 1993-12-07 1995-06-22 Univ Dresden Tech Zahnriemengetriebe
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
US5665378A (en) * 1994-09-30 1997-09-09 Davis; Roosevelt Transdermal therapeutic formulation
US5665731A (en) * 1995-06-07 1997-09-09 Hennessey; Richard K. Method and composition for treating with a vasodilator inflammation, bone loss and detachment of teeth as associated with periodontal
US5667799A (en) * 1995-10-30 1997-09-16 Caldwell; Larry J. Method for treating headache pain with topical local anesthetic compositions
US6017963A (en) 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US6916487B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of antiemetics
AUPN814496A0 (en) * 1996-02-19 1996-03-14 Monash University Dermal penetration enhancer
US7094422B2 (en) * 1996-02-19 2006-08-22 Acrux Dds Pty Ltd. Topical delivery of antifungal agents
US6929801B2 (en) * 1996-02-19 2005-08-16 Acrux Dds Pty Ltd Transdermal delivery of antiparkinson agents
US6916486B2 (en) * 1996-02-19 2005-07-12 Acrux Dds Pty Ltd Transdermal delivery of analgesics
US6998138B2 (en) * 1996-02-19 2006-02-14 Acrux Dds Pty. Ltd. Topical delivery of anti-alopecia agents
US6923983B2 (en) 1996-02-19 2005-08-02 Acrux Dds Pty Ltd Transdermal delivery of hormones
US5707612A (en) * 1996-04-08 1998-01-13 Alzo, Inc. Use urethane polymers of castor oil skin and personal care product compositiions
DE19616539A1 (de) * 1996-04-25 1997-11-06 Luitpold Pharma Gmbh Acetylsalicylsäure enthaltende alkoholische Lösungen zur perkutanen Anwendung, deren Verwendung zur antithrombotischen Therapie sowie Arzneimittel
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
CA2283929C (en) * 1997-05-20 2007-02-20 Larry J. Caldwell Method for treating headache pain with topical local anesthetic compositions
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
US6103771A (en) * 1998-03-20 2000-08-15 Caldwell Galer Incorporated Method of treating neuroma pain
US6120756A (en) * 1998-08-19 2000-09-19 Philip I. Markowitz Topical anionic salicylate for disorders of the skin
DE60034667T2 (de) 1999-02-01 2008-03-13 Dermal Research Laboratories, Inc. Pharmazeutische zusammensetzung aus komplexen kohlenhydraten und deren anwendung
US6733794B1 (en) * 1999-12-17 2004-05-11 Edward L. Ingram Topical composition for antiseptic and analgesic purposes
US7879824B2 (en) 2001-07-31 2011-02-01 Dermal Research Laboratories, Inc. Methods of preventing or treating diseases and conditions using complex carbohydrates
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US6635274B1 (en) 2000-10-27 2003-10-21 Biochemics, Inc. Solution-based transdermal drug delivery system
US20070003980A1 (en) * 2001-03-27 2007-01-04 Woods Daniel F Efficient methods to isolate effectors of proteins involved in olfactory or chemosensory pathways and efficient methods to use these effectors to alter organism olfaction, chemosensation, or behavior
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
KR101233030B1 (ko) 2005-02-23 2013-02-13 프렉사 팔마큐티칼스, 인코포레이티드. 운동 장애와 다른 ｃｎｓ 증상의 치료에 이용되는 도파민수송체 저해물질
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
DK1937276T3 (da) 2005-10-12 2013-02-11 Besins Healthcare Luxembourg Forbedret testosterongel og fremgangsmåde til anvendelse deraf
AU2007325918B2 (en) 2006-11-03 2013-10-17 Durect Corporation Transdermal delivery systems comprising bupivacaine
CA2727710C (en) * 2008-06-11 2016-11-01 Biochemics, Inc. Control of blood vessel physiology to treat skin disorders
EP2373346B1 (en) 2008-09-10 2019-06-12 BioChemics, Inc. Ibuprofen for topical administration
BRPI0914192A2 (pt) 2008-09-22 2015-11-03 Biochemics Inc distribuição transdérmica de fármaco usando um osmólito e agente vasoativo
EP2352543B1 (en) 2008-12-04 2019-04-03 BioChemics, Inc. Methods and compositions for tattoo removal
AU2010237599A1 (en) * 2009-04-14 2011-12-08 Medortus (Uk) Ltd Gel compositions for administration of pharmaceutically active compounds
WO2014028608A1 (en) * 2012-08-14 2014-02-20 South Dakota State University Method of treating skin disorders using nanoscale delivery devices and transdermal enhancing compositions
KR20170023776A (ko) 2014-02-26 2017-03-06 루마 세러퓨틱스 인코포레이티드 자외선 광선 치료 장치들 및 방법들
EP3413852A4 (en) 2016-02-09 2019-07-31 Luma Therapeutics, Inc. METHOD, COMPOSITIONS AND DEVICES FOR TREATING PSORIASIS BY PHOTOTHERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE679276A (fr) * 1965-05-13 1966-09-16 Sarec Sa Applications thérapeutiques de cyclohexyl-phénols
US3527864A (en) * 1966-11-18 1970-09-08 Procter & Gamble Compositions for topical application to animal tissue and method of enhancing penetration thereof
US3472931A (en) * 1969-01-17 1969-10-14 Foster Milburn Co Percutaneous absorption with lower alkyl amides
RO69197A2 (ro) * 1976-05-05 1981-05-30 Intreprinderea De Antibiotice,Ro Gel cu actiune antiseptica rinofaringiana
AU520987B2 (en) * 1978-05-08 1982-03-11 Victor Alexander Garten Anti-arthritic preparation

Also Published As

Publication number Publication date
IE53467B1 (en) 1988-11-23
PT75208B (en) 1985-10-04
US4440777A (en) 1984-04-03
EP0069385A2 (en) 1983-01-12
EP0069385B1 (en) 1987-10-14
DE3277453D1 (en) 1987-11-19
IE821570L (en) 1983-01-07
PT75208A (en) 1982-08-01
EP0069385A3 (en) 1984-02-22
JPS5815910A (ja) 1983-01-29
ATE30209T1 (de) 1987-10-15
GR77254B (da) 1984-09-11

Similar Documents

Publication Publication Date Title
DK302782A (da) Anvendelse af eucalypol til at foroege et praeparats optagelse gennem huden
JP2608762B2 (ja) 多汗症の治療剤
US6676953B2 (en) Antifungal composition and method for human nails
NO891379D0 (no) Anestetisk hudfuktingspreparat og fremgangsmaate for fremstilling derav.
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
DE122012000021I1 (de) Hautpenetrationsforderer sowie diese verwendende.
Suringa Treatment of superficial onychomycosis with topically applied glutaraldehyde: A preliminary study
US4083965A (en) Method of and composition for relieving itch, pain and swelling resulting from insect stings and bites and skin contact with noxious plants
SE8101374L (sv) Kompositioner innehallande n,n-dietyl-m-toluamid
NO912864D0 (no) Stedsspesifikk invivo aktivering av terapeutiske forbindelser.
DE3762018D1 (de) Abwaschbare topische zubereitung zur therapie der psoriasis.
ES2137125B1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
WO2000072883A3 (en) Pharmaceutical transdermal compositions
JP2958662B2 (ja) 発毛・養毛促進剤
US5176918A (en) Topical medicament
US5973010A (en) Composition for healing skin wounds
KR920005967A (ko) 순환계 질병치료와 미용약물 치료에 사용되는 성분물
RU1814558C (ru) "Средство "Паноцид" дл борьбы с демодекозом собак"
FI832672A0 (fi) Medicinskt foerfarande och preparat
JPS60188316A (ja) 口腔用抗炎症剤
JPS5735511A (en) Dermatic medicine for external application
IT1297139B1 (it) Composizioni per la somministrazione transdermica e dermica di sostanze biologicamente attive
JPS61130207A (ja) 養毛剤
KR930700110A (ko) 세포독성제 및 침투 증진제로 이루어진 조성물
TH16108B (th) ยาชาที่มีผลเฉพาะแห่งสำหรับใช้ภายนอก

Legal Events

Date Code Title Description
ATS Application withdrawn